Active-ingredient Dossier
Estradiol Hemihydrate
Active-ingredient Dossier for Estradiol Hemihydrate (estrogen hormone replacement). Australian brands, products, PBS listings, PBAC outcomes — compiled…
- Brand: BIJUVA
- Brand: ANGELIQ
- Brand: ZUMENON
- Therapeutic area: Reproductive Health
What is
Estradiol Hemihydrate Estradiol Hemihydrate is an estrogen hormone replacement therapy.
Australian brands containing
Estradiol Hemihydrate — ESTRADERM MX — SANDRENA — VAGIFEM — ZUMENON — BIJUVA — ANGELIQ — ESTROFEM — TRISEQUENS
Therapeutic areas
Estradiol Hemihydrate is registered across three therapeutic areas: Reproductive Health (3 brands), Women's Health (3 brands), and Oncology (2 brands).
Sponsor landscape
The ingredient is marketed by six sponsors: Novo Nordisk Pharmaceuticals, Bayer, Theramex, Juno Pharmaceuticals, Orion Pharma (AUS), and Arrotex Pharmaceuticals.
PBS and regulatory activity
Three brands containing Estradiol Hemihydrate are PBS-listed, with the latest PBS schedule dated 1 May 2026. The most recent PBAC outcome was recorded on 1 July 2024, and the latest AusPAR was issued on 27 April 2022.